Pyelotubular Reflux: Understanding and Treatment
Introduction:
Pyelotubular reflux (r. pyelotubularis) is a medical condition that refers to the backflow of urine from the renal calexes into the tubular system of the kidneys. This condition can cause a variety of problems and requires close medical monitoring and, in some cases, treatment. In this article we will look at the main aspects of pyelotubular reflux, its causes, symptoms and available treatments.
Causes of pyelotubular reflux:
Pyelotubular reflux can be caused by various factors. One of the most common causes is an abnormality in the structure of the ureters and their connection to the renal calexes. This may occur due to birth defects or develop over time. Other possible causes include backflow of urine from the bladder into the renal calexes, as well as possible abnormalities in the muscle tone of the bladder.
Symptoms of pyelotubular reflux:
Symptoms of pyelotubular reflux can vary depending on the extent and severity of the backflow of urine. Some patients may have no obvious symptoms, while others may exhibit the following signs:
-
Recurrent urinary tract infections: Recurrent urinary tract infections may indicate the presence of pyelotubular reflux. This is because backflow of urine can promote infection of the kidneys and urinary tract.
-
Low back pain: Some patients may experience pain in the lower back, especially when urinating or due to urolithiasis.
-
Increased pressure in the kidneys: Pyelotubular reflux can cause increased pressure in the kidneys, which can ultimately lead to damage to the kidney tissue.
Treatment methods for pyelotubular reflux:
Treatment for pyelotubular reflux depends on its severity and causes. In some cases, observation and conservative measures may be sufficient to control symptoms and prevent complications. However, in more serious cases, surgery may be required. Here are some of the treatments that may be used:
-
Prophylactic antibiotics: Patients with recurrent urinary tract infections may be given prophylactic antibiotics. This helps prevent infections and reduce the risk of complications.
-
Ureterorenosistotomy: In some cases, especially with severe pyelotubular reflux, surgery may be required. Ureterorenosistotomy is a procedure in which the ureter is transferred and rerouted below the level of urine backflow to prevent reflux.
-
Endoscopic treatment: In some cases, pyelotubular reflux can be treated with endoscopic methods. This involves using special tools and techniques to repair ureteral abnormalities and restore normal urine flow.
-
Drug treatment: In some cases, medications may be used to control symptoms and improve kidney function. This may include medications to reduce kidney pressure or medications to improve bladder muscle tone.
Conclusion:
Pyelotubular reflux is a condition that requires close medical monitoring and, in some cases, treatment. If present, patients may experience recurrent urinary tract infections and other symptoms that can affect their quality of life. It is important to consult a doctor for an accurate diagnosis and appropriate treatment. Modern treatment methods, including surgical and conservative approaches, can control the symptoms of pyelotubular reflux and prevent complications, providing patients with a better quality of life.
Pyelotubular reflux is a form of cystinuria, manifested by metabolic disorders in the interstitium, diffuse changes in the kidneys, which are in the nature of scar-ulcerative processes and papillary formations. Refluxes are located mainly on the lateral surface of the kidney. There are two types of them: on the lower surface of the upper calyx of the renal cortex (pyelonephritis latus venosus) and on its surface (pyelitis). In the primary variant, there is no damage to the mucous membrane of the ureter and the posterior wall of the bladder; patients develop chronic colic against the background of kidney inflammation, and a urinary tract infection develops. For the secondary variant, damage to the mucous membranes of the bladder and upper urinary tract is more typical; the urethra accounts for 34%. This form of reflux is accompanied by impaired urine passage and a sharp decrease in urine volume.